Diabetes News

Following on the heels of Eli Lilly and Novo Nordisk, Sanofi announced it will reduce the price of two of its branded insulins as well as cap out-of-pocket costs at $35 per month for people with commercial health insurance.

Among patients with type 2 diabetes and albuminuric chronic kidney disease, canagliflozin reduced kidney and cardiovascular events independent of age or sex, according to data published in the American Journal of Kidney Diseases.

Young children using a hybrid closed-loop insulin delivery system had a greater time in range at 13 weeks compared with those receiving standard care, according to a study published in The New England Journal of Medicine.

Low testosterone among men and low sex hormone-binding globulin among women are associated with progression from prediabetes to diabetes, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

Novo Nordisk is the latest company to announce a large reduction in insulin prices as it stated it will cut prices for multiple insulin products by up to 75% in 2024.

A survey conducted by Bayer reveals physicians agree there is a need for earlier testing and more transparent communication with patients who have chronic kidney disease associated with type 2 diabetes.

Adults with type 2 diabetes and atherosclerotic cardiovascular disease were less likely to need insulin and had a lower insulin dose requirement with 5 mg or 15 mg ertugliflozin daily compared with placebo, according to study data.

Adults with type 1 diabetes using insulin glargine had comparable continuous glucose monitoring metrics at 12 weeks as those who used insulin degludec, according to a presenter.

NEW ORLEANS — With the use of cognitive behavioral therapy, a smartphone app helped patients with type 2 diabetes reduce HbA1c with less medication and insulation intensification vs. controls, a speaker reported.

Children of women with type 2 diabetes who took 1,000 mg metformin twice daily during pregnancy had a similar BMI z score at age 2 years compared with those of women using placebo, according to study data.